Active chest wall oscillation treatment	Sham chest wall oscillation treatment	Patient satisfaction	17091	17265	Satisfaction with study treatment was also high, even in the sham HFCWO group (active vs. sham HFCWO: comfortable, 88% vs. 92%, p = 0.67; feel better, 80% vs. 85%, p = 0.73).
Active chest wall oscillation treatment	Sham chest wall oscillation treatment	Secondary outcomes including spontaneously expectorated sputum volume, and forced expired volume in 1 second	1543	1609	There were no significant differences in other secondary outcomes.
Active chest wall oscillation treatment	Sham chest wall oscillation treatment	Patient satisfaction	1316	1376	Patient satisfaction was also similarly high in both groups.
Active chest wall oscillation treatment	Sham chest wall oscillation treatment	Patient adherence	1239	1315	Patient adherence was similarly high in both groups (91% vs. 93%; p = 0.70).
Active chest wall oscillation treatment	Sham chest wall oscillation treatment	Dyspnea improvement	1377	1542	After four treatments, a higher proportion of patients in the active treatment group had a clinically significant improvement in dyspnea (70.8% vs. 42.3%, p = 0.04).
